Similar Progression of Morphological and Metabolic Phenotype in R6/2 Mice with Different CAG Repeats Revealed by In Vivo Magnetic Resonance Imaging and Spectroscopy-Reference-Cited by-同舟云学术

Similar Progression of Morphological and Metabolic Phenotype in R6/2 Mice with Different CAG Repeats Revealed by In Vivo Magnetic Resonance Imaging and Spectroscopy

Published:2016-10-01 Issue:3 Volume:5 Page:271-283
ISSN:1879-6397
Container-title:Journal of Huntington's Disease
language:
Short-container-title:JHD

Author:

Sawiak Stephen J.¹²,Wood Nigel I.³,Morton A. Jennifer³

Affiliation:

1. Wolfson Brain Imaging Centre, University of Cambridge, Box 65 Addenbrooke’s Hospital, Cambridge, UK

2. Behavioural and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK

3. Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK

Publisher

IOS Press

Subject

Cellular and Molecular Neuroscience,Neurology (clinical)

Reference55 articles.

1. Huntington’s disease;Walker;Lancet,2007

2. Huntingtin localization in brains of normal and Huntington’s disease patients;Sapp;Ann Neurol,1997

3. Progressive formation of inclusions in the striatum and hippocampus of mice transgenic for the human Huntington’s disease mutation;Morton;J Neurocytol,2000

4. Mouse models of Huntington’s disease;Menalled;Trends Pharmacol Sci,2002

5. Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats;Rubinsztein;Am J Hum Genet,1996

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Magnetic Resonance Imaging to Detect Structural Brain Changes in Huntington’s Disease: A Review of Data from Mouse Models;Journal of Huntington's Disease;2024-09-10

2. Neurochemical changes in the progression of Huntington's disease: A meta-analysis of in vivo 1H-MRS studies;Neurobiology of Disease;2024-09

3. Neuroimaging, Urinary, and Plasma Biomarkers of Treatment Response in Huntington’s Disease: Preclinical Evidence with the p75NTR Ligand LM11A-31;Neurotherapeutics;2021-03-30